Pokemon Go - The new summer hit!

Rolling Pebbles playing Pokémon Go

If you’ve been on the internet — or, um, outside — lately, you may have noticed that a game called Pokémon Go is suddenly taking the world by storm. It may have you wondering, especially if you were born before 1984, just what the hell is going on.

Pokémon is a Nintendo franchise that launched in the 1990s. In its world, "trainers" travel the world to catch varied monsters called Pokémon — rats, dragons, swordlike creatures, and more — and use these critters to fight each other. The trainer’s goal is to "catch ’em all," as the franchise’s slogan suggests, and become a Pokémon master by defeating prestigious trainers known as gym leaders and Elite Four.

So what is Pokémon Go? Unlike previous Pokémon games, it’s not for Nintendo’s handheld consoles; it’s a free download for Android and iOS devices. It also doesn’t play at all like previous Pokémon games: Although the goal is still to catch ’em all, Pokémon Go is an augmented reality game — it mixes real-world elements with the game. It was released on July 6 2016 in USA and Australia  and it is available for download thru Google play and Apple store. As of today it is available to play it outside the official release countries by installing offline apk package available on various wed sites. Be aware that using non trusted sources may open a door to your device  for malicious components.
July 15,2016 update : As of Friday morning, Pokemon Go was out in Australia, the United States, Germany, the United Kingdom, Italy, New Zealand, Spain and Portugal, according to Tech Crunch. John Hanke, an executive with developer Niantic, told Reuters Friday he planned to roll out the game in about 200 countries and regions. 

Human trials of a Zika vaccine just approved

21-June-2016
The US Food and Drug Administration (FDA) has approved the first human tests of an experimental Zika virus vaccine, the makers of the drug announced on Monday.
Called GLS–5700, the medication will be used in a clinical trial involving 40 healthy people, and represents the first major step towards ultimately immunizing people against Zika – which was declared a global public health emergency by the World Health Organization (WHO) in February.
GLS–5700 works by stimulating the body's immune system to defend itself against Zika. Synthetic fragments of viral DNA are injected into the skin, prompting the immune system's T cells to generate antibodies to fight the infection.
It's worth pointing out that just because GLS–5700 has reached human testing, there's no guarantee it will turn out to safely immunize people against Zika. The vaccine has been tested successfully in small and large animal models, but clinical trials in humans could take several years to demonstrate that the treatment is safe, and there's no guarantee it will ultimately prove effective or make it through subsequent testing phases.
GLS–5700 isn't the only Zika vaccine candidate currently in development.It has been reported that at least one company in India and one in France are expected to begin human trials later this year.